Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight
by amelius on Thursday February 16, 2017 @09:34AM
(#13660099)
This means that only one line of further development will be possible, since a patent is basically a license for a monopoly.
Instead, we could grant subsidies and have multiple developments working in parallel.
Yes, one of the two labs discovered CRISPR. OK, now what? It's not a treatment at this point, it's just a technique. So someone has to invest a ton of money to turn the technique into a therapy for humans. And I would bet that investment will absolutely dwarf what's been spent so far.